← United States · All US Insider Profiles
US INSIDER PROFILE · NON-SCORING RESEARCH
Hoffman Michael B
Director
Identity: SEC reporting-owner CIK · Reporting-owner CIK: 0001290208
Purchase history
- Companies traded
- 1
- Purchases · 12M
- 8
- Purchases · 24M
- 8
- Average purchase
- $532.1K
- Median purchase
- $159.9K
- Gross purchase value
- $4.3M
Companies: Annovis Bio, Inc.
8 SEC accession(s) · 0 joint-owner event(s). Values are reported Form 4 transaction values in USD.
Qualifying purchase disclosures
| Published | Company | Ticker | Role | Reported value | SEC source |
|---|---|---|---|---|---|
| 2026-05-21 | Annovis Bio, Inc. | ANVS | Director | $142.8K | Open filing |
| 2026-04-03 | Annovis Bio, Inc. | ANVS | Director | $1.5M | Open filing |
| 2025-12-08 | Annovis Bio, Inc. | ANVS | Director | $193.8K | Open filing |
| 2025-11-25 | Annovis Bio, Inc. | ANVS | Director | $159.9K | Open filing |
| 2025-11-25 | Annovis Bio, Inc. | ANVS | Director | $159.9K | Open filing |
| 2025-11-21 | Annovis Bio, Inc. | ANVS | Director | $69.9K | Open filing |
| 2025-11-18 | Annovis Bio, Inc. | ANVS | Director | $31.6K | Open filing |
| 2025-11-12 | Annovis Bio, Inc. | ANVS | Director | $2.0M | Open filing |
Post-purchase outcomes
Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.
No completed point-in-time price outcome is available yet.
Research patterns
- First purchase in 12M
- 1/8
- Large purchase ≥ $100k
- 6/8
- Cluster buying · 15D
- 5/8
- Buying the dip
- 0/—
Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.
Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.